Clinical Efficacy Analysis of Botulinum Toxin Type A Combined with Superficial Radiotherapy after Chest Keloid Surgery
Aesthetic Plastic Surgery · 2025
DOI: 10.1007/s00266-025-04886-w ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Ya Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Graduate School, Hebei North University, Qiaoxi District, Zhangjiakou City, 075000, Hebei Province, China. Hauptthemen laut MEDLINE: Keloid, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Health Commission of Hebei Province.
Abstract (Originalsprache)
BACKGROUND: There are many treatments for keloid. In recent years, botulinum toxin type A(BTX-A)has been proposed to treat keloid. The purpose of our study was to observe the clinical effect of BTX-A combined with superficial radiotherapy after chest keloid surgery. METHODS: 60 patients with medium and large chest keloid treated from October 2021 to October 2023 were selected and randomly divided into group A and group B, with 30 cases in each group. Keloid resection was performed in both groups first, group A was treated with BTX-A combined with superficial radiotherapy, group B only received early superficial radiotherapy after surgery, and the therapeutic effect of the two groups was compared. RESULTS: After 6 months follow-up observation, the total effective rate and satisfaction of group A were higher than those of group B, and the Vancouver scar scale(VSS) score of group A was lower than that of group B, the difference was statistically significant (P < 0.05). CONCLUSIONS: We concluded that immediate injection of BTX-A combined with superficial radiotherapy after chest keloid surgery was superior to simple superficial radiotherapy after surgery, with higher patient satisfaction and lower recurrence rate, which was worthy of clinical application. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Graduate School, Hebei North University, Qiaoxi District, Zhangjiakou City, 075000, Hebei Province, China.
- Department of Plastic and Cosmetic Surgery, Department of Surgery, First Hospital of Qinhuangdao, No. 258, Wenhua Road, Haigang District, Qinhuangdao City, 066000, Hebei Province, China.
- Department of Plastic and Cosmetic Surgery, Department of Surgery, First Hospital of Qinhuangdao, No. 258, Wenhua Road, Haigang District, Qinhuangdao City, 066000, Hebei Province, China. 878648593@qq.com.
ORCID-Profile: Jiaxin Wang
Förderung
- Health Commission of Hebei Province
Zitieren
APA
Gao, Y., Li, W., Li, Z., Wu, F., & Wang, J. (2025). Clinical Efficacy Analysis of Botulinum Toxin Type A Combined with Superficial Radiotherapy after Chest Keloid Surgery. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-04886-w
Vancouver
Gao Y, Li W, Li Z, Wu F, Wang J. Clinical Efficacy Analysis of Botulinum Toxin Type A Combined with Superficial Radiotherapy after Chest Keloid Surgery. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-04886-w
BibTeX
@article{Gao2025,
author = {Gao, Ya and Li, Wenbo and Li, Zhongxing and Wu, Fenglian and Wang, Jiaxin},
title = {Clinical Efficacy Analysis of Botulinum Toxin Type A Combined with Superficial Radiotherapy after Chest Keloid Surgery},
journal = {Aesthetic Plastic Surgery},
year = {2025},
doi = {10.1007/s00266-025-04886-w}
}
EUVIMED